Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Inventories — Raw materials & supplies by Quarter
Inventories — Raw materials & supplies ($M) ($M)
Pfizer Inventories — Raw materials & supplies: $898M in Q2 2026, down 12.7% from a year earlier.
Latest, Q2 2026
898
Period ended Jun 28, 2026
Change on a year earlier
-12.7%
1,029 in Q2 2025
History
46 quarters
Since Q1 2015
Sources
45
Documents cited below
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Inventories Footnote.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Inventories — Raw materials & supplies ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 28, 2026 | 898 | -12.7% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2026 | Mar 29, 2026 | 923 | -18.8% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2025 | Dec 31, 2025 | 907 | -7.1% | Form 10-Q (filed 2026-08-04) ↗ |
| Q3 2025 | Sep 28, 2025 | 945 | -19.5% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 29, 2025 | 1,029 | -11.0% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 30, 2025 | 1,137 | +0.8% | Form 10-Q (filed 2025-05-05) ↗ |
| Q4 2024 | Dec 31, 2024 | 976 | -3.1% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2024 | Sep 29, 2024 | 1,174 | +47.3% | Form 10-Q (filed 2024-11-04) ↗ |
| Q2 2024 | Jun 30, 2024 | 1,156 | +35.4% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 1,128 | +49.4% | Form 10-Q (filed 2024-05-08) ↗ |
| Q4 2023 | Dec 31, 2023 | 1,007 | +17.2% | Form 10-K (filed 2025-02-27) ↗ |
| Q3 2023 | Oct 1, 2023 | 797 | -56.0% | Form 10-Q (filed 2023-11-08) ↗ |
| Q2 2023 | Jul 2, 2023 | 854 | -58.2% | Form 10-Q (filed 2023-08-09) ↗ |
| Q1 2023 | Apr 2, 2023 | 755 | -49.7% | Form 10-Q (filed 2023-05-10) ↗ |
| Q4 2022 | Dec 31, 2022 | 859 | -13.6% | Form 10-K (filed 2024-02-22) ↗ |
| Q3 2022 | Oct 2, 2022 | 1,813 | +103.5% | Form 10-Q (filed 2022-11-09) ↗ |
| Q2 2022 | Jul 3, 2022 | 2,041 | +137.6% | Form 10-Q (filed 2022-08-10) ↗ |
| Q1 2022 | Apr 3, 2022 | 1,502 | +78.8% | Form 10-Q (filed 2022-05-11) ↗ |
| Q4 2021 | Dec 31, 2021 | 994 | +38.8% | Form 10-K (filed 2023-02-23) ↗ |
| Q3 2021 | Oct 3, 2021 | 891 | +17.2% | Form 10-Q (filed 2021-11-12) ↗ |
| Q2 2021 | Jul 4, 2021 | 859 | +14.2% | Form 10-Q (filed 2021-08-12) ↗ |
| Q1 2021 | Apr 4, 2021 | 840 | +11.0% | Form 10-Q (filed 2021-05-13) ↗ |
| Q4 2020 | Dec 31, 2020 | 716 | +6.5% | Form 10-K (filed 2022-02-24) ↗ |
| Q3 2020 | Sep 27, 2020 | 760 | -0.3% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2020 | Jun 28, 2020 | 752 | +53.5% | Form 10-Q (filed 2020-08-06) ↗ |
| Q1 2020 | Mar 29, 2020 | 757 | +35.2% | Form 10-Q (filed 2020-05-07) ↗ |
| Q4 2019 | Dec 31, 2019 | 672 | +23.1% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2019 | Sep 29, 2019 | 762 | -9.2% | Form 10-Q (filed 2019-11-07) ↗ |
| Q2 2019 | Jun 30, 2019 | 490 | -36.9% | Form 10-Q (filed 2019-08-08) ↗ |
| Q1 2019 | Mar 31, 2019 | 560 | -32.1% | Form 10-Q (filed 2019-05-09) ↗ |
| Q4 2018 | Dec 31, 2018 | 546 | -30.7% | Form 10-K (filed 2020-02-27) ↗ |
| Q3 2018 | Sep 30, 2018 | 839 | -4.6% | Form 10-Q (filed 2018-11-08) ↗ |
| Q2 2018 | Jul 1, 2018 | 776 | -4.6% | Form 10-Q (filed 2018-08-09) ↗ |
| Q1 2018 | Apr 1, 2018 | 825 | +2.0% | Form 10-Q (filed 2018-05-10) ↗ |
| Q4 2017 | Dec 31, 2017 | 788 | -0.6% | Form 10-K (filed 2019-02-28) ↗ |
| Q3 2017 | Oct 1, 2017 | 879 | +2.0% | SEC Filing ↗ |
| Q2 2017 | Jul 2, 2017 | 813 | -14.4% | SEC Filing ↗ |
| Q1 2017 | Apr 2, 2017 | 809 | -3.7% | SEC Filing ↗ |
| Q4 2016 | Dec 31, 2016 | 793 | -8.5% | Form 10-K (filed 2018-02-22) ↗ |
| Q3 2016 | Oct 2, 2016 | 862 | -6.6% | SEC Filing ↗ |
| Q2 2016 | Jul 3, 2016 | 950 | +84.8% | SEC Filing ↗ |
| Q1 2016 | Apr 3, 2016 | 840 | +76.8% | SEC Filing ↗ |
| Q4 2015 | Dec 31, 2015 | 867 | – | Form 10-K (filed 2017-02-23) ↗ |
| Q3 2015 | Sep 27, 2015 | 923 | – | SEC Filing ↗ |
| Q2 2015 | Jun 28, 2015 | 514 | – | SEC Filing ↗ |
| Q1 2015 | Mar 29, 2015 | 475 | – | SEC Filing ↗ |
Cite this data
StockData. (2026). Pfizer Inventories — Raw materials & supplies ($M), quarterly Q1 2015–Q2 2026 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/inv-raw
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.